IS4924A - Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum - Google Patents

Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum

Info

Publication number
IS4924A
IS4924A IS4924A IS4924A IS4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A IS 4924 A IS4924 A IS 4924A
Authority
IS
Iceland
Prior art keywords
treatment
acetic acid
acid derivatives
thrombotic disorders
piperidine acetic
Prior art date
Application number
IS4924A
Other languages
English (en)
Icelandic (is)
Inventor
George Allen David
David Eldred Colin
Leonard Mitchell William
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4924A publication Critical patent/IS4924A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS4924A 1996-06-21 1998-12-15 Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum IS4924A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
IS4924A true IS4924A (is) 1998-12-15

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4924A IS4924A (is) 1996-06-21 1998-12-15 Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum

Country Status (17)

Country Link
EP (1) EP0912555A1 (tr)
JP (1) JP2000512648A (tr)
KR (1) KR20000022041A (tr)
AP (1) AP9801417A0 (tr)
AR (1) AR008245A1 (tr)
AU (1) AU3261197A (tr)
BR (1) BR9709930A (tr)
CA (1) CA2258753A1 (tr)
CZ (1) CZ424698A3 (tr)
EA (1) EA199801015A1 (tr)
ID (1) ID17052A (tr)
IL (1) IL127464A0 (tr)
IS (1) IS4924A (tr)
NO (1) NO985974L (tr)
PL (1) PL330797A1 (tr)
TR (1) TR199802665T2 (tr)
WO (1) WO1997049699A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401831A1 (en) 2001-07-03 2004-03-31 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
TW200401641A (en) * 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
PL378120A1 (pl) * 2003-02-14 2006-03-06 Wyeth Heterocyklilo-3-sulfonyloindazole jako ligandy 5-hydroksytryptaminy
EP2001865A1 (en) 2006-04-05 2008-12-17 Wyeth a Corporation of the State of Delaware Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
EP2118062A1 (en) 2007-01-10 2009-11-18 F. Hoffmann-Roche AG Sulfonamide derivatives as chymase inhibitors
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU2915892A (en) * 1991-11-14 1993-06-15 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
AR008245A1 (es) 1999-12-29
WO1997049699A1 (en) 1997-12-31
BR9709930A (pt) 1999-08-10
NO985974D0 (no) 1998-12-18
KR20000022041A (ko) 2000-04-25
EA199801015A1 (ru) 1999-08-26
TR199802665T2 (tr) 1999-03-22
ID17052A (id) 1997-12-04
EP0912555A1 (en) 1999-05-06
AU3261197A (en) 1998-01-14
IL127464A0 (en) 1999-10-28
CA2258753A1 (en) 1997-12-31
AP9801417A0 (en) 1998-12-31
CZ424698A3 (cs) 1999-05-12
PL330797A1 (en) 1999-06-07
NO985974L (no) 1999-02-17
JP2000512648A (ja) 2000-09-26

Similar Documents

Publication Publication Date Title
NO990700D0 (no) Propionsyrederivater og anvendelsen herav
NO20004098D0 (no) FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser
NO2008002I2 (no) Protiokonazol og salter derav
NO20001754D0 (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE69813570D1 (de) 5-alkyl-2-arylaminophenylessigsäure und derivative
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
IS4481A (is) Díhýdrópyramídín og notkun þeirra
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
DK0741594T3 (da) Fototermisk terapeutisk anordning og metode
NO992297D0 (no) FremgangsmÕte og nye forbindelser
EE05067B1 (et) Aminoproplfosfiinhapped ning nende kasutamine meditsiinis
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
FI940216A0 (fi) Kinoloni- ja naftyridonikarboksyylihappojohdannaiset
DK0928333T3 (da) Metabolsk optimerede mælkesyrebakterier og deres anvendelse
IS1930B (is) Notkun samsetningar H+, K+ -ATPasa tálma og sykurstera í meðhöndlun á nefsepagerum
NO950936D0 (no) 5-vinyl- og 5-etinylchinolon- og naftyridonkarboksylsyrer
IS4924A (is) Píperidín ediksýruafleiður og notkun þeirra við meðhöndlun á segamyndunar truflunum
ID22841A (id) Penggunaan larutan-larutan asam manonatrium iminodiasetat di dalam pembuatan asam n-fosfonometiliminodiasetat
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
IS4140A (is) Notkun á ferróseni og/eða ferrósenafleiðum
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO981002L (no) Karboksylsyrederivater, deres fremstilling og anvendelse
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory